Identification of Potential BRAF Inhibitor Joint Therapy Targets in PTC based on WGCAN and DCGA.

J Cancer · 2021 · PMC7890315 · PMID 33613767

Europe PMC DOI

hedged sentence

0.0920

closest p · 1.8× alpha

0.0920

boldest claim

The sentences

did not reach statistical significancep -value = 0.092so close (0.05 < p ≤ 0.1)

Besides, cases with high expression of the NECTIN4 also showed lower relapse-free probability though the result did not reach statistical significance ( p -value = 0.092, figure 5 A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.